Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
VPS35 mutations have been identified as a cause of autosomal dominantly inherited
Parkinson's disease
(PD). VPS35 interacts with
VPS26A
in the retromer complex that links mitochondrial and lysosomal pathways, which have both been shown to be dysfunctional in PD. Thus, mutations in
VPS26A
may be associated with PD. To test this hypothesis, we screened 245 idiopathic PD patients and 185 control subjects for mutations in the retromer subunit
VPS26A
. We found 2 novel missense variants in patients and 2 known missense variants in control subjects. The missense variants were unlikely to be disease causing, suggesting that
VPS26A
mutations are not a frequent cause of PD.
...
PMID:Mutations in VPS26A are not a frequent cause of Parkinson's disease. 2441 87
We recently showed that mutation of the VPS35 gene can cause late-onset
Parkinson's disease
. In the present study we sequenced 702 affected subjects from the Mayo Clinic
Parkinson's disease
patient-control series for the VPS29 and
VPS26A
/B genes. We identified only 2 rare nonsynonymous variants in the
VPS26A
p.K93E and VPS29 p.N72H. The results show that mutations in the genes composing the retromer cargo recognition subunit are not a common cause of
Parkinson's disease
.
...
PMID:Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease. 2468 91